Advanced in Obsessive-Compulsive Disorder (OCD)

Stephan Ruhrmann

Kerpener Str. 62, 
Koeln, NW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Obsessive-Compulsive Disorder (OCD)
Kerpener Str. 62, 
Koeln, NW, DE 
OverviewLocationsClinical Research

Overview

Stephan Ruhrmann practices in Koeln, Germany. Mr. Ruhrmann is rated as an Advanced expert by MediFind in the treatment of Obsessive-Compulsive Disorder (OCD). His top areas of expertise are Schizophrenia, Obsessive-Compulsive Disorder (OCD), Anorexia, and Tourette Syndrome.

His clinical research consists of co-authoring 151 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 14 articles in the study of Obsessive-Compulsive Disorder (OCD).

Gender
Male

Locations

Kerpener Str. 62, Koeln, NW 50937, Germany
Other Locations
Kerpener Str. 62, Koeln, NW 50934, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Enhancing Recovery in Early Schizophrenia - a Multi-center, Two-arm, Double-blind, Randomized Phase II Trial Investigating Cannabidiol Vs. Placebo As an Add-on to an Individualized Antipsychotic Treatment
Enhancing Recovery in Early Schizophrenia - a Multi-center, Two-arm, Double-blind, Randomized Phase II Trial Investigating Cannabidiol Vs. Placebo As an Add-on to an Individualized Antipsychotic Treatment
Enrollment Status: Recruiting
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drug: Cannabidiol as Add-On
Study Phase: Phase 2

150 Total Publications

Active treatment of affective disturbances may improve functional outcomes in patients in the early state of psychosis: Results of the PRONIA study.
Active treatment of affective disturbances may improve functional outcomes in patients in the early state of psychosis: Results of the PRONIA study.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: October 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ruhrmann's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile